Dr. Jason Thomas Ricciuti, MD

Dr. Ricciuti practices at SSM Health St. Mary's Hospital - St. Louis in Saint Louis, Missouri, part of SSM Health Care.

Dr. Ricciuti's NPI, 1609263409, was assigned on April 20, 2015. Dr. Ricciuti graduated from University of South Florida College of Medicine in 2015. Dr. Ricciuti holds Missouri license 2022034017.

Dr. Ricciuti's primary practice is SSM Health St. Mary's Hospital - St. Louis, at 6420 Clayton Rd, Saint Louis, MO 63117 in St. Louis County. The practice phone is (314) 768-8000.

Dr. Ricciuti's primary practice is SSM Health St. Mary's Hospital - St. Louis in Saint Louis, Missouri, part of SSM Health Care. Dr. Ricciuti is also affiliated with SSM Health Saint Louis University Hospital. The medical group on file is SLUCare Physician Group. Dmand AI also links Dr. Ricciuti to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ricciuti practices, 4 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Ricciuti's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Ricciuti is licensed in Missouri.

CMS data shows 77 Medicare services from Dr. Ricciuti across 3 procedure codes in 2024, all of them office visits, for 61 Medicare patients. Medicare paid $8,139 for them. Every service was in an office.

CMS counts 61 Medicare patients who saw Dr. Ricciuti in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ricciuti's median patient age at 66, with 100% women.

In 2024, Dr. Ricciuti wrote 340 Medicare Part D claims for 59 patients. 96% of them were for generic drugs. CMS names the drug for 187 of them, across 9 drugs with 11 or more claims each, at $12,080 in total drug cost. In 2023, CMS named 28 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Ricciuti for performance year 2024, reported as part of a group. Dr. Ricciuti accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ricciuti as offering telehealth.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Ricciuti, published from 2015 to 2025. 2023 was the busiest year, with 2. The most frequent topics are Ovarian Neoplasms, Tumor Microenvironment and Carcinoma, Ovarian Epithelial. Dr. Ricciuti has published most often in Gynecol Oncol. Dr. Ricciuti's most frequent co-authors are Emese Zsiros, MD, Brahm Hillel Segal, MD and Emad Alqassim, MD, PhD.

Dr. Ricciuti graduated from University of South Florida College of Medicine in 2015.